S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:GHRS

GH Research (GHRS) Stock Price, News & Analysis

$10.71
-0.38 (-3.43%)
(As of 03/27/2024 ET)
Today's Range
$10.71
$11.47
50-Day Range
$5.63
$11.09
52-Week Range
$5.05
$14.64
Volume
40,781 shs
Average Volume
133,514 shs
Market Capitalization
$557.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$39.50

GH Research MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
268.8% Upside
$39.50 Price Target
Short Interest
Bearish
4.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.14mentions of GH Research in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.96) to ($1.17) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.19 out of 5 stars

Medical Sector

727th out of 939 stocks

Pharmaceutical Preparations Industry

338th out of 435 stocks

GHRS stock logo

About GH Research Stock (NASDAQ:GHRS)

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

GHRS Stock Price History

GHRS Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
GH Research PLC GHRS
H.C. Wainwright Sticks to Their Buy Rating for GH Research (GHRS)
See More Headlines
Receive GHRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GH Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/27/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GHRS
Fax
N/A
Employees
32
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$39.50
High Stock Price Target
$40.00
Low Stock Price Target
$39.00
Potential Upside/Downside
+268.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-35,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$557.24 million
Optionable
Optionable
Beta
0.79
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Florian Schonharting M.Sc. (Econ) (Age 55)
    Co-Founder & Non-Executive Chairman of the Board
  • Dr. Theis Terwey M.D. (Age 48)
    Co-Founder & CEO
  • Mr. Magnus Halle (Age 27)
    Co-Founder & MD of Ireland
  • Ms. Julie Ryan F.C.A. (Age 38)
    Vice President of Finance
  • Mr. Aaron Cameron M.B.A. (Age 38)
    Chief Operating Officer
  • Mr. Naoise Gaffney
    VP & Head of Intellectual Property

GHRS Stock Analysis - Frequently Asked Questions

Should I buy or sell GH Research stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GH Research in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GHRS shares.
View GHRS analyst ratings
or view top-rated stocks.

What is GH Research's stock price target for 2024?

2 brokerages have issued 12 month target prices for GH Research's stock. Their GHRS share price targets range from $39.00 to $40.00. On average, they predict the company's share price to reach $39.50 in the next twelve months. This suggests a possible upside of 268.8% from the stock's current price.
View analysts price targets for GHRS
or view top-rated stocks among Wall Street analysts.

How have GHRS shares performed in 2024?

GH Research's stock was trading at $5.80 at the beginning of the year. Since then, GHRS stock has increased by 84.7% and is now trading at $10.71.
View the best growth stocks for 2024 here
.

When is GH Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our GHRS earnings forecast
.

How were GH Research's earnings last quarter?

GH Research PLC (NASDAQ:GHRS) issued its earnings results on Thursday, February, 29th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.01.

What ETFs hold GH Research's stock?

ETFs with the largest weight of GH Research (NASDAQ:GHRS) stock in their portfolio include AdvisorShares Psychedelics ETF (PSIL).iShares MSCI Ireland ETF (EIRL).

When did GH Research IPO?

GH Research (GHRS) raised $150 million in an IPO on Friday, June 25th 2021. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share.

Who are GH Research's major shareholders?

GH Research's stock is owned by a variety of retail and institutional investors. Top institutional investors include BVF Inc. IL (20.59%), Verition Fund Management LLC (0.00%), Mirae Asset Global Investments Co. Ltd. (0.00%), Citadel Advisors LLC (0.19%), AdvisorShares Investments LLC (0.00%) and Barclays PLC (0.06%).

How do I buy shares of GH Research?

Shares of GHRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GHRS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners